Compare Cardinal Health Inc (CAH) vs Nebius Group NV (NBIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Nebius Group NV — how do they compare? Cardinal Health Inc trades at $230.98 (market cap $54.46B), while Nebius Group NV trades at $255.82 (market cap $70.46B). The key difference: Nebius Group NV is the larger of the two by market cap, and Cardinal Health Inc pays a 0.88% dividend while Nebius Group NV pays none. Which is the better fit depends on your goals.
| CAH | NBIS | |
|---|---|---|
Market Cap | $54.46B | $70.46B |
Sector | Health | Technology |
52-Week High | $240.26 | $286.69 |
52-Week Low | $146.04 | $64.06 |
Enterprise Value | $58.49B | $72.48B |
Dividend Yield | 0.88% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →
